Nanosonics Past Earnings Performance
Past criteria checks 5/6
Nanosonics has been growing earnings at an average annual rate of 5.6%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 15.9% per year. Nanosonics's return on equity is 8.9%, and it has net margins of 9.6%.
Key information
5.6%
Earnings growth rate
5.5%
EPS growth rate
Medical Equipment Industry Growth | 5.8% |
Revenue growth rate | 15.9% |
Return on equity | 8.9% |
Net Margin | 9.6% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Returns On Capital At Nanosonics (ASX:NAN) Paint A Concerning Picture
Feb 27Some Confidence Is Lacking In Nanosonics Limited (ASX:NAN) As Shares Slide 33%
Jan 24Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Nov 08Investors Will Want Nanosonics' (ASX:NAN) Growth In ROCE To Persist
Oct 04Is Nanosonics Limited (ASX:NAN) Potentially Undervalued?
Jul 12Nanosonics (ASX:NAN) Will Be Hoping To Turn Its Returns On Capital Around
May 16Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 09This Is Why Nanosonics Limited's (ASX:NAN) CEO Compensation Looks Appropriate
Nov 11A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Oct 28What Does Nanosonics Limited's (ASX:NAN) Share Price Indicate?
Oct 06A Look At The Fair Value Of Nanosonics Limited (ASX:NAN)
Jul 18At AU$3.36, Is Nanosonics Limited (ASX:NAN) Worth Looking At Closely?
Jun 26Nanosonics (ASX:NAN) Will Want To Turn Around Its Return Trends
Jun 07A Look At The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Mar 08Nanosonics Limited (ASX:NAN) Analysts Just Cut Their EPS Forecasts
Feb 15Is Now The Time To Look At Buying Nanosonics Limited (ASX:NAN)?
Feb 02Nanosonics Limited's (ASX:NAN) CEO Looks Due For A Compensation Raise
Nov 12Returns Are Gaining Momentum At Nanosonics (ASX:NAN)
Aug 03An Intrinsic Calculation For Nanosonics Limited (ASX:NAN) Suggests It's 21% Undervalued
Mar 30Returns On Capital - An Important Metric For Nanosonics (ASX:NAN)
Mar 15Time To Worry? Analysts Are Downgrading Their Nanosonics Limited (ASX:NAN) Outlook
Feb 28Nanosonics Limited's (ASX:NAN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 19Is There Now An Opportunity In Nanosonics Limited (ASX:NAN)?
Feb 07What Did Nanosonics' (ASX:NAN) CEO Take Home Last Year?
Jan 26How Much Of Nanosonics Limited (ASX:NAN) Do Insiders Own?
Jan 14Here's Why Nanosonics's (ASX:NAN) Statutory Earnings Are Arguably Too Conservative
Jan 01Estimating The Intrinsic Value Of Nanosonics Limited (ASX:NAN)
Dec 20Is There More Growth In Store For Nanosonics' (ASX:NAN) Returns On Capital?
Dec 07Can You Imagine How Elated Nanosonics' (ASX:NAN) Shareholders Feel About Its 302% Share Price Gain?
Nov 25Is Nanosonics' (ASX:NAN) Share Price Gain Of 250% Well Earned?
Jul 28Revenue & Expenses BreakdownBeta
How Nanosonics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 164 | 16 | 88 | 32 |
30 Sep 23 | 165 | 18 | 87 | 31 |
30 Jun 23 | 166 | 20 | 85 | 29 |
31 Mar 23 | 154 | 15 | 81 | 27 |
31 Dec 22 | 141 | 10 | 77 | 25 |
30 Sep 22 | 131 | 7 | 73 | 24 |
30 Jun 22 | 120 | 4 | 68 | 22 |
31 Mar 22 | 120 | 7 | 64 | 21 |
31 Dec 21 | 121 | 11 | 60 | 20 |
30 Sep 21 | 112 | 10 | 57 | 19 |
30 Jun 21 | 103 | 9 | 54 | 17 |
31 Mar 21 | 99 | 7 | 51 | 17 |
31 Dec 20 | 95 | 6 | 49 | 16 |
30 Sep 20 | 97 | 8 | 48 | 16 |
30 Jun 20 | 100 | 10 | 48 | 16 |
31 Mar 20 | 96 | 11 | 47 | 14 |
31 Dec 19 | 92 | 12 | 46 | 13 |
30 Sep 19 | 88 | 13 | 42 | 12 |
30 Jun 19 | 84 | 14 | 38 | 11 |
31 Mar 19 | 78 | 12 | 36 | 11 |
31 Dec 18 | 71 | 11 | 34 | 11 |
30 Sep 18 | 66 | 8 | 33 | 10 |
30 Jun 18 | 61 | 6 | 33 | 10 |
31 Mar 18 | 61 | 6 | 31 | 10 |
31 Dec 17 | 61 | 6 | 29 | 10 |
30 Sep 17 | 64 | 16 | 28 | 10 |
30 Jun 17 | 68 | 26 | 28 | 9 |
31 Mar 17 | 65 | 26 | 26 | 9 |
31 Dec 16 | 63 | 25 | 25 | 8 |
30 Sep 16 | 53 | 13 | 25 | 8 |
30 Jun 16 | 43 | 0 | 25 | 7 |
31 Mar 16 | 33 | -5 | 25 | 7 |
31 Dec 15 | 23 | -10 | 24 | 6 |
30 Sep 15 | 23 | -8 | 21 | 5 |
30 Jun 15 | 22 | -5 | 18 | 5 |
31 Mar 15 | 24 | -2 | 17 | 4 |
31 Dec 14 | 26 | 2 | 16 | 3 |
30 Sep 14 | 24 | 0 | 16 | 2 |
30 Jun 14 | 21 | -3 | 17 | 1 |
31 Mar 14 | 21 | -3 | 15 | 1 |
31 Dec 13 | 20 | -3 | 14 | 1 |
30 Sep 13 | 18 | -4 | 14 | 1 |
30 Jun 13 | 15 | -6 | 14 | 0 |
Quality Earnings: NAN has high quality earnings.
Growing Profit Margin: NAN's current net profit margins (9.6%) are higher than last year (7.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NAN's earnings have grown by 5.6% per year over the past 5 years.
Accelerating Growth: NAN's earnings growth over the past year (53.2%) exceeds its 5-year average (5.6% per year).
Earnings vs Industry: NAN earnings growth over the past year (53.2%) exceeded the Medical Equipment industry 10.1%.
Return on Equity
High ROE: NAN's Return on Equity (8.9%) is considered low.